348 related articles for article (PubMed ID: 7516822)
1. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity.
Bunn PA; Chan D; Dienhart DG; Tolley R; Tagawa M; Jewett PB
Cancer Res; 1992 Jan; 52(1):24-31. PubMed ID: 1309227
[TBL] [Abstract][Full Text] [Related]
5. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Woll PJ; Rozengurt E
Cancer Res; 1990 Jul; 50(13):3968-73. PubMed ID: 1693879
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptides on human lung and breast cancer cells.
Bunn PA; Dienhart DG; Chan D; Tagawa M; Jewett P
J Natl Cancer Inst Monogr; 1992; (13):145-51. PubMed ID: 1389687
[TBL] [Abstract][Full Text] [Related]
7. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
8. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
Sethi T; Langdon S; Smyth J; Rozengurt E
Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
[TBL] [Abstract][Full Text] [Related]
9. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
10. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
11. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
12. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
13. Peptide hormones and lung cancer.
Moody TW
Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
15. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
16. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
Gross AJ; Steinberg SM; Reilly JG; Bliss DP; Brennan J; Le PT; Simmons A; Phelps R; Mulshine JL; Ihde DC
Cancer Res; 1993 Jan; 53(1):67-74. PubMed ID: 8380126
[TBL] [Abstract][Full Text] [Related]
19. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin.
Sethi T; Rozengurt E
Cancer Res; 1991 Jul; 51(13):3621-3. PubMed ID: 1711414
[TBL] [Abstract][Full Text] [Related]
20. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.
Seckl MJ; Higgins T; Widmer F; Rozengurt E
Cancer Res; 1997 Jan; 57(1):51-4. PubMed ID: 8988040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
